News - Page 83 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

Post published:October 12, 2022
Post category:Press Release

Read more about the article COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in Treatment Resistant Depression at Capital Markets Day

COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in Treatment Resistant Depression at Capital Markets Day

Post published:October 12, 2022
Post category:Press Release

Read more about the article Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

Clearmind Medicine Featured in “Psychedelics Tonight,” Streaming on ALTRD.TV

Post published:October 11, 2022
Post category:Press Release

Read more about the article PsyBio Therapeutics Reaches Agreement to Conduct Initial Psilocybin Clinical Trial

PsyBio Therapeutics Reaches Agreement to Conduct Initial Psilocybin Clinical Trial

Post published:October 11, 2022
Post category:Press Release

Read more about the article Optimi Health Announces Closing of Strategic Non-Brokered Private Placement

Optimi Health Announces Closing of Strategic Non-Brokered Private Placement

Post published:October 11, 2022
Post category:Press Release

Read more about the article Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for Treatment of Fibromyalgia

Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for Treatment of Fibromyalgia

Post published:October 11, 2022
Post category:Press Release

Read more about the article Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022

Post published:October 8, 2022
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. Announces Executive Changes

Reunion Neuroscience Inc. Announces Executive Changes

Post published:October 7, 2022
Post category:Press Release

Read more about the article Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health

Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health

Post published:October 7, 2022
Post category:Press Release

Read more about the article Silo Pharma to Present at the Dawson James Small Cap Growth Conference on October 12

Silo Pharma to Present at the Dawson James Small Cap Growth Conference on October 12

Post published:October 6, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.